OAM
MEDP icon

Origin Asset Management’s Medpace MEDP Stock Holding History

Origin Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-509
Closed -$206K – 18
2024
Q1 		$206K Buy
+509
New +$179K 0.06% 15
2023
Q1 		– Sell
-1,151
Closed -$244K – 29
2022
Q4 		$244K Buy
+1,151
New +$230K 0.07% 12
2019
Q2 		– Sell
-7,584
Closed -$447K – 118
2019
Q1 		$447K Sell
7,584
-47,200
-86% -$2.82M 0.04% 87
2018
Q4 		$2.9M Buy
54,784
+43,500
+386% +$2.39M 0.26% 81
2018
Q3 		$676K Hold
11,284
– – 0.04% 92
2018
Q2 		$485K Hold
11,284
– – 0.03% 93
2018
Q1 		$394K Hold
11,284
– – 0.02% 102
2017
Q4 		$409K Buy
+11,284
New +$396K 0.02% 104

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Origin Asset Management's MEDP Position: Q2 2024 in Review

Origin Asset Management sold out of Medpace (MEDP) in Q2 2024, closing a stake of 509 shares — an estimated $206K sold.

Origin Asset Management first reported a position in MEDP in Q4 2017 and held it in 8 quarters. The position peaked at $2.9M in Q4 2018. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

  • Origin Asset Management reported no remaining Medpace position as of Q2 2024 after selling out during the quarter.
  • Origin Asset Management sold 509 Medpace shares in Q2 2024, an estimated $206K.
  • Origin Asset Management first reported a position in Medpace in Q4 2017 and held it in 8 quarters.
  • Origin Asset Management's Medpace position peaked at $2.9M in Q4 2018.
  • 623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on Origin Asset Management's 13F filing for Q2 2024, filed 25 Jul 2024.